Volunteer Donate Get Help

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Novel Treatment for HCL

Published: September 18, 2018

Source: Oncology Nurse Advisor

Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia (HCL), the U.S. Food & Drug Administration said yesterday.

... More >>.

Baffling High-Risk Leukemia Solved

Published: September 12, 2018

Source: St. Jude Children's Research Hospital

St. Jude Children's Research Hospital investigators have unraveled the origins and identified mutations with a perplexing form of acute leukemia, The landmark study appears today as an advance online publica ... More >>.

Better Treatment for Leukemia

Published: August 09, 2018

Source: University of Illinois at Chicago

Previous research has revealed that patients with acute myeloid leukemia who also have a particular mutation in a gene called NPM1 have a higher rate of remission with chemotherapy. About one-third of leukem ... More >>.

Soaring Cost of Cancer Care

Published: August 07, 2018

Source: Leukemia & Lymphoma Society

As cost for cancer care skyrocket---projected to be $173 billion by 2020, a 39 percent increase from 2010. The Leukemia & Lymphoma Society (LLS) is renewing its call for action to ease the cost of cancer ... More >>.

CAR T Guidelines Developed

Published: August 06, 2018

Source: University of Texas M.D. Anderson Cancer Center

Almost one year after the U.S. Food and Drug Administration (FDA) approval of chimeric antigen receptor (CAR) T-cell therapy for children with acute lymphoblastic leukemia (ALL), researchers at The Universit ... More >>.

FDA Approval for New Precision Medicine

Published: July 20, 2018

Source: Leukemia & Lymphoma Society

Progress in treating acute myeloid leukemia (AML), a blood cancer that takes more than 10,000 lives in the United States each year, took an important step forward today with the U.S. Food Drug Administration ... More >>.

Clinical Stages May Predict Outcomes in CLL

Published: July 20, 2018

Author: James Nam, PharmD

Source: Cancer Therapy Advisor

Determining the clinical stage of patients with chronic lymphocytic leukemia (CLL) may be an effective prognostic marker for time to next therapy (TTNT) and overall survival (OS), according to a study publis ... More >>.

Factors Associated With AML

Published: July 09, 2018

Author: Randi Hernandez

Source: Cancer Therapy Advisor

Using deep sequencing techniques, investigators of a study published in Nature determined they were able to tease out the predictors that are associated with the development of acute myeloid leukemi ... More >>.

Researchers Develop Synthetic T-Cells

Published: June 27, 2018

Source: Unversity of Califonia - Los Angeles

UCLA researchers have developed synthetic T lymphocytes, or T cells, that are near-perfect facsimiles of human T cells. The ability to create the artificial cells could be a key step toward more effective dr ... More >>.

Remission in CML After 96 Weeks

Published: June 25, 2018

Author: Alexander M. Castellino, PhD

Source: Cancer Therapy Advisor

A long-term follow-up of the ENEST freedom study reported that 96 weeks after stopping treatment, nearly half (48.9%) of patients with chronic myeloid leukemia (CML) with front-line treatment with nilotinib ... More >>.

©2015 Stephanie Robinson Foundation | Privacy Policy